This article advocates for expanded research into the dynamic relationship between tryptamine levels, activation of the aryl hydrocarbon receptor (AHR) signalling pathway, and MAO enzyme activity, which is an intriguing and promising research direction for neurogenerative, neurodevelopmental and psychiatric disorders. This evidence concerns the gene AHR and psychiatric disorder.